Mina Therapeutics

Provider of RNA activation therapeutics

placeLondon, England, United Kingdom calendar_todayFounded 2008 groups18 employees language minatx.com

Registered entities

Investor mix

19 investors on record; lead investors include aMoon, Nxera, Boehringer Ingelheim.

Investor typeCountShare
Venture capital526%
Bank & private debt211%
Other / undisclosed1263%
Coming soon